Cart
sales@molnova.com
4-Hydroxyindole
CAS No. 2380-94-1
4-Hydroxyindole( —— )
Catalog No. M37709 CAS No. 2380-94-1
4-Hydroxyindole is an aromatic heterocyclic compound that is widely studied in both scientific research and laboratory experiments.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product Name4-Hydroxyindole
-
NoteResearch use only, not for human use.
-
Brief Description4-Hydroxyindole is an aromatic heterocyclic compound that is widely studied in both scientific research and laboratory experiments.
-
Description4-Hydroxyindole is a member of the class of hydroxyindoles that is 1H-indole substituted by a hydroxy group at position 4. 4-Hydroxyindole is an important raw material or intermediate in the synthesis of pharmaceutical products and industrial polymers.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2380-94-1
-
Formula Weight133.15
-
Molecular FormulaC8H7NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 15.71 mg/mL (117.99 mM; Ultrasonic ) H2O : 1.43 mg/mL (10.74 mM; Ultrasonic)
-
SMILESOC1=C2C=CNC2=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nenad Manevski, et al. Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos. 2010 Mar;38(3):386-95.?
molnova catalog
related products
-
1-O-trans-caffeoyl-5...
1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid
-
Isophysalin G
Reference standards. Physalin G analogue.
-
PACAP (1-38), human,...
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.
